Spinal Elements Expands Launch of Clutch Interspinous Process Device

By Julie A. Vetalice

Spinal Elements commenced full launch of the Clutch® interspinous process device for treatment of various posterior thoracolumbar pathologies.

FDA 510(k) cleared in 2017, the device features a spring-activated mechanism designed to maintain active compression against the spinous processes to resist loosening/migration. Bone-opposing surfaces are enhanced with the company's Ti-Bond® technology to support stability and long-term fixation.

In 2016, the company announced a warranty for Ti-Bond devices against delaminating, chipping, peeling, shedding or generating debris during surgery, and also against fracture in whole or in part, coating delamination, pseudarthrosis, implant migration, subsidence or trauma for one year post-op. Spinal Elements will replace the implant free of charge if any of these events occur.

Sources: Spinal Elements; ORTHOWORLD Inc.

Spinal Elements Clutch Interspinous Process Device

Image courtesy of Spinal Elements

Tags: Product Launch